Health Krystal Biotech Receives FDA Approval for the First-Ever Redosable Gene Therapy, VYJUVEK™… Jason Junior May 19, 2023 <!-- Name:DistributionId Value:8843111 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4573 -->…
Health Krystal Biotech Announces Publication of Phase 1 and 2 Clinical Trial (GEM 1/2 Study) of Beremagene… Jason Junior Mar 29, 2022 Treatment with B-VEC demonstrated robust functional COL7 expression followed by its assembly into basement membrane-associated anchoring fibrils Treatment with B-VEC improved durable wound closure in patients with recessive dystrophic…